Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Lobar vs Sublobar Lung Resection for Early-Stage Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

The Annals of thoracic surgery - 1 Jul 2026

Pohlman Alexander, Odeh Bilal, Raad Wissam, Lubawski James, Coughlin Julia M, Abdelsattar Zaid M

Abstract excerpt

BACKGROUND: Randomized controlled trials have shown that sublobar resections for small peripheral non-small cell lung cancer (NSCLC) are oncologically noninferior to lobar resections. However, these studies did not factor in epidermal growth factor receptor (EGFR) mutations. In this context, we sought to determine survival differences between sublobar and lobar resection for EGFR-mutant vs wild-type NSCLC....

Topics

Join the communities discussing this publication.

Aged
Carcinoma, Non-Small-Cell Lung
ErbB Receptors
Lung Neoplasms
Neoplasm Staging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Propensity Score

Source

Identifiers

PMID: 41933780
DOI: 10.1016/j.athoracsur.2026.03.045

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Lobar vs Sublobar Lung Resection for Early-Stage Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.PMID 41933780Read ↗

Sublobar Resection in Early Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutant.Semantic proximity Read ↗

Surgical results of the Lung Cancer Mutation Consortium 3 trial: A phase II multicenter single-arm study to investigate the efficacy and safety of atezolizumab as neoadjuvant therapy in patients with stages IB-select IIIB resectable non-small cell lung cancer.Semantic proximity Read ↗

Sleeve Lobectomy After Neoadjuvant Therapy for Non-Small Cell Lung Cancer: A Systematic Review and Meta-analysisSemantic proximity Read ↗

Outcomes After Surgical Resection of Early-stage Lung Adenocarcinomas With Epidermal Growth Factor Receptor Mutations.Semantic proximity Read ↗

A Single Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally-Advanced Non-small Cell Lung Cancer (NSCLC)Semantic proximity Read ↗

Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS RegistrySemantic proximity Read ↗

Contemporary outcomes of en bloc stapling of the pulmonary artery, bronchus, and lymph nodes during lobectomy for non-small cell lung cancer: a retrospective studySemantic proximity Read ↗

Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.Semantic proximity Read ↗

Clinical outcome of subcentimeter non-small cell lung cancer after surgical resection: single institution experience of 105 patients.Semantic proximity Read ↗

Anatomical Resections Improve Survival Following Lung Metastasectomy of Colorectal Cancer Harboring KRAS Mutations.Semantic proximity Read ↗

ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.